# Commercial Bancgroup, Inc.: overview

CBK · Nasdaq · CIK 1981546 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbk.md) · [Financials](/companies/cbk/financials.md) · [Filings](/companies/cbk/filings.md) · [Insiders](/companies/cbk/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.74](/filings/0001213900-25-110914.md) | not reported | [0.72](/filings/0001213900-26-055885.md) | [0.73](/filings/0001213900-26-088408.md) | [0.77](/filings/0001213900-25-110914.md) | not reported | [0.70](/filings/0001213900-26-055885.md) | [0.74](/filings/0001213900-26-088408.md) |
| Free cash flow | $m | not reported | [9.7 d](/filings/0001213900-26-033659.md) | [11.7](/filings/0001213900-26-055885.md) | [6.8 d](/filings/0001213900-26-088408.md) | [7.9 d](/filings/0001213900-25-110914.md) | [8.8 d](/filings/0001213900-26-033659.md) | [13.1](/filings/0001213900-26-055885.md) | [8.8 d](/filings/0001213900-26-088408.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: |
| Revenue | $m | not reported | not reported |
| Gross margin | % | not reported | not reported |
| Operating margin | % | not reported | not reported |
| Net margin | % | not reported | not reported |
| Diluted EPS | $ per share | [2.54](/filings/0001213900-26-033659.md) | [2.95](/filings/0001213900-26-033659.md) |
| Free cash flow | $m | [35.6](/filings/0001213900-26-033659.md) | [35.2](/filings/0001213900-26-033659.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cbk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $22.2m | 852,885 |  | Reduced −176,641 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.7m | 670,950 |  | Added +185,254 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.7m | 331,598 |  | Added +2,151 |
| [Petiole USA ltd](/funds/1600202.md) | 2026-06-30 | $9.4m | 291,014 |  | Unchanged |
| [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $7.5m | 233,110 |  | Reduced −15,148 |
| [RAFFLES ASSOCIATES LP](/funds/1169581.md) | 2026-06-30 | $7.5m | 233,110 |  | Reduced −15,148 |
| [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $7.2m | 223,763 |  | Reduced −1,743 |
| [MENDON CAPITAL ADVISORS CORP](/funds/1177043.md) | 2026-06-30 | $6.9m | 213,668 |  | Reduced −101,965 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.8m | 209,839 |  | Added +40,946 |
| [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $6.3m | 195,622 |  | Reduced −94,027 |

## Recent filings

[All 94 filings](/companies/cbk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 17:23 ET | [8-K](/filings/0001213900-26-112550.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-112550 |
| 2026-08-12 | 16:38 ET | [10-Q](/filings/0001213900-26-088408.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088408 |
| 2026-07-27 | 16:10 ET | [8-K](/filings/0001213900-26-081811.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-081811 |
| 2026-05-13 | 16:43 ET | [10-Q](/filings/0001213900-26-055885.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055885 |
| 2026-04-27 | 16:37 ET | [SCHEDULE 13D](/filings/0000898432-26-000286.md) | Ownership report, active investor | 0000898432-26-000286 |
| 2026-04-27 | 15:11 ET | [8-K](/filings/0001213900-26-047976.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-047976 |
| 2026-03-31 | 17:20 ET | [DEF 14A](/filings/0001213900-26-037647.md) | Proxy statement, period 2026-04-27 | 0001213900-26-037647 |
| 2026-03-24 | 17:26 ET | [10-K](/filings/0001213900-26-033659.md) | Annual report, period 2025-12-31 | 0001213900-26-033659 |
| 2026-01-28 | 16:10 ET | [8-K](/filings/0001213900-26-008822.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008822 |
| 2026-01-26 | 16:40 ET | [8-K](/filings/0001213900-26-007744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-007744 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-033659.md), filed Mar 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1981546
- Tickers: CBK
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: TN
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:25 ET. No prices; not investment advice.